Key result
COVID-19 in pregnancy is linked to increased risk of major cardiovascular complications.
Why the study?
Cardiovascular complications of SARS-CoV-2 infection are well-described in the general population but data remain limited among pregnant patients.
Pregnant patients hospitalized with severe COVID-19 should undergo routine cardiac testing (ECG, biomarkers) and be managed by a multidisciplinary cardio-obstetric team due to the high risk of cardiovascular complications.
Answers are grounded in this paper and cite their sources.
Supports cardiac monitoring in pregnant COVID-19 patients; leaves open optimal protocols pending prospective validation.
Cardiovascular complications of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection are well-described in the general population but remain limited among pregnant patients. This review summarizes data from case reports, case series, and observational studies of cardiovascular manifestations of corona virus disease 2019 (COVID-19) in pregnant patients and provides recommendations to the cardiovascular clinician regarding management considerations in this vulnerable population. Pregna is an immunocompromised state in which cardiovascular demands are increased. Cardiovascular complications of COVID-19 that have been described in pregnancy include myocardial injury, cardiomyopathy, thromboembolism, pre-eclampsia and arrhythmia. Physiologic and cardiovascular changes in pregnancy predispose pregnant patients with COVID-19 to more severe illness than the general population. Black or Hispanic race, obesity, diabetes, hypertension and lung disease are risk factors for more severe infection, maternal death and adverse perinatal outcomes. Pregnant patients with severe COVID-19 disease compared with non-pregnant age-matched women with COVID infection are more likely to be admitted to the intensive care unit (ICU), receive mechanical ventilation and require advanced mechanical circulatory support. Cardiovascular complications of COVID-19 in pregnant patients requires further attention, particularly given the anticipated increase in birth volume and ongoing nature of COVID-19 pandemic with novel variants. Clinicians should have a lower threshold for cardiac testing and multidisciplinary management in pregnant women with severe COVID-19 disease. Given the persistence of COVID-19 within our communities, diagnostic laboratory and imaging testing for high-risk pregnant patients hospitalized with COVID-19 infection should be routine. We strongly urge the implementation of a cardio-obstetric multidisciplinary team in individually managing these high-risk patients in an effort to improve maternal and fetal outcomes.
No takes yet. Share an insight, caveat, or question.
Pruzansky et al. (2022) conducted a review in COVID-19 in pregnancy. COVID-19 infection vs. Pregnant patients without COVID-19 or non-pregnant patients with COVID-19 was evaluated. COVID-19 infection in pregnancy increases the risk of cardiovascular complications including myocardial injury, cardiomyopathy, thromboembolism, preeclampsia, and arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: